FDA Guidance on Decentralized Clinical Trials (DCTs) in the United States
FDA Guidance on Decentralized Clinical Trials (DCTs) in the United States FDA’s Approach to Decentralized Clinical Trials in the United States Introduction Decentralized clinical trials (DCTs) have emerged as a pivotal innovation in U.S. clinical research, particularly after the COVID-19 pandemic. The Food and Drug Administration (FDA) has recognized DCTs as a way to improve…
Read More “FDA Guidance on Decentralized Clinical Trials (DCTs) in the United States” »